❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Immunology ❭ Lymphoma biology group [Myklebust] ❭ Group members ❭ Previous members ❭

Previous members

Sarah E. Josefsson

Lise K. Bollum

 
Page visits: 688
Scroll to top

Home Dept. of Cancer Immunology Lymphoma biology group [Myklebust]

  • Group members
    • Previous members
  • Publicatons
  • Introduction (in Norwegian)
  • Links
  • Tweets

Recent publications

Huse K, Bai B, Hilden VI, Bollum LK, Våtsveen TK, Munthe LA, Smeland EB, Irish JM, Wälchli S, Myklebust JH (2022)
Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression
J Immunol, 209 (10), 2042-2053
DOI 10.4049/jimmunol.2200144, PubMed 36426942

Yri OE, Aass N, Kaasa S (2022)
[Not Available]
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0696, PubMed 36416654

Isaksen KT, Beiske K, Smeland EB, Jørgensen J, Brodtkorb M, Myklebust JH, Jerkeman M, Meriranta L, Karjalainen-Lindsberg ML, Leppä S, Scott DW, Holte H, Blaker YN (2020)
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma
EJHaem, 2 (1), 104-108
DOI 10.1002/jha2.109, PubMed 35846101

More

Get in touch

Go to LabMyklebust on Twitter

More tweets

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Email: trond.olav.berg@rr-research.no

Cookie policy

Accessibility statement (in Norwegian)